{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:12:17Z","timestamp":1780600337403,"version":"3.54.1"},"reference-count":21,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the transvenous ICD, to prevent lead-related complications associated with the latter. The absence of intravascular or intracardiac components offers potential advantages to pediatric patients. Aims: The aim of the study is to present an overview of our experience with S-ICDs in the pediatric center that, currently, has performed the largest number of implantations in children in Poland. Methods: Retrospective analysis of data from medical history, qualification, implantation procedure, and S-ICD post-implantation observations in 11 pediatric patients were performed. Results: S-ICDs were implanted in 11 patients, 8 boys and 3 girls, aged 12\u201317 years. The S-ICD was implanted for primary prevention in seven patients: four with hypertrophic cardiomyopathy (HCM), two with dilated cardiomyopathy (DCM), and one with arrhythmogenic right ventricular cardiomyopathy (ARVC). It was implanted for secondary prevention in four patients: two with sudden cardiac arrest (SCA) in the course of idiopathic ventricular fibrillation (IVF), one with long QT syndrome (LQTS) after probable SCA, and one with Brugada syndrome after SCA. In all patients, the device was implanted intramuscularly. One patient did not have a defibrillation test performed due to the presence of an intracardiac thrombus. In one patient, during screening, it was decided to implant an electrode on the right side of the sternum. There were no early or late complications with any of the procedures. So far, no inadequate discharges have been observed. Conclusions: Our results prove the efficacy of the S-ICD treatment option along with technically simple surgery, which supports its further and more widespread application in children.<\/jats:p>","DOI":"10.3390\/ijerph191811661","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T03:48:04Z","timestamp":1663300084000},"page":"11661","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8711-0891","authenticated-orcid":false,"given":"Piotr","family":"Wieniawski","sequence":"first","affiliation":[{"name":"Department of Paediatric Cardiology and General Paediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Buczy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Cardiac and General Paediatric Surgery, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Grabowski","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Winter","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, University of D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6416-4106","authenticated-orcid":false,"given":"Bo\u017cena","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Paediatric Cardiology and General Paediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.hrthm.2016.06.024","article-title":"Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach","volume":"13","author":"Schneider","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5603\/CJ.a2018.0024","article-title":"Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center","volume":"26","author":"Grabowski","year":"2019","journal-title":"Cardiol. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.5114\/aoms.2019.83817","article-title":"Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland","volume":"16","author":"Kaczmarek","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.33963\/KP.15294","article-title":"Regional anesthesia of the hemithorax for the implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD)","volume":"78","author":"Sadownik","year":"2020","journal-title":"Kardiologia Polska"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.hrthm.2017.03.019","article-title":"Cardiac implantable electronic device infections: Who is at greatest risk?","volume":"14","author":"Joy","year":"2017","journal-title":"Heart Rhythm"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/eurheartj\/ehv507","article-title":"The subcutaneous implantable cardioverter defibrillator: State-of-the-art review","volume":"38","author":"McLeod","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An Entirely Subcutaneous Implantable Cardioverter\u2013Defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"New Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5603\/KP.2015.0010","article-title":"A subcutaneous implantable cardioverter-defibrillator\u2014The first implantation in Poland","volume":"73","author":"Kaczmarek","year":"2015","journal-title":"Kardiologia Polska"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/europace\/euw297","article-title":"Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: Long-term performance and complications","volume":"19","author":"Winter","year":"2016","journal-title":"Europace"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.33963\/KP.15469","article-title":"Children and young adults treated with transvenous and subcutaneous implantable cardioverter-defibrillators: A 22-year single-center experience and new perspectives","volume":"78","author":"Lewandowski","year":"2020","journal-title":"Kardiol. Pol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study","volume":"70","author":"Boersma","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacep.2017.07.017","article-title":"Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies","volume":"3","author":"Liu","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2017.09.213","article-title":"Selecting the right defibrillator in the younger patient: Transvenous, epicardial or subcutaneous?","volume":"250","author":"Bogush","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/eurheartj\/ehs017","article-title":"Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: Cause for caution","volume":"33","author":"Jarman","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacep.2020.07.010","article-title":"Subcutaneous Implantable Cardioverter-Defibrillators in Pediatrics and Congenital Heart Disease: A Pediatric and Congenital Electrophysiology Society Multicenter Review","volume":"6","author":"Dechert","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jacep.2017.08.017","article-title":"Long-Term Experience with the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults","volume":"3","author":"Bettin","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/europace\/euy139","article-title":"Subcutaneous implantable cardioverter-defibrillator: Is it ready for use in children and young adults? A single-centre study","volume":"20","author":"Silvetti","year":"2018","journal-title":"Europace"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12471-018-1186-1","article-title":"Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients","volume":"26","author":"Quast","year":"2018","journal-title":"Neth. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1111\/jce.14746","article-title":"Neglected lead tip erosion: An unusual case of S-ICD inappropriate shock","volume":"31","author":"Mitacchione","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/18\/11661\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:32:36Z","timestamp":1760142756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/18\/11661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":21,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijerph191811661"],"URL":"https:\/\/doi.org\/10.3390\/ijerph191811661","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}